genomics

Malaysian Genomics to Collaborate on Cannabinoid R&D

Source Node:
Time Stamp: February 24, 2023 7:08 AM - Modified On: February 24, 2023 - Published By:
Source Cluster:
Republished By Plato

Group joins MAHSA University and Kensana Health to develop phytopharmaceutical and biotechnology products for commercialisation PETALING JAYA, Malaysia, Feb 24, 2023 - (ACN Newswire) - Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, today announced that the Group has entered into a strategic collaboration with Kensana Health Canada and MAHSA University for the research and development (R&D) of phytopharmaceutical and biotechnology products that can lead to commercialisation. [caption id="attachment_1975650" align="alignnone" width="350"] Dato' Alvin Joseph Nesakumar, Executive Director of Malaysian Genomics[/caption] Kensana Health Canada is a biotechnology specialist

Wikisoft Corp. signs Letter of Intent to Acquire Disruptive Blockchain Tech Company – Etheralabs LLC.

Source Node:
Time Stamp: February 9, 2022 10:25 AM - Modified On: February 9, 2022 - Published By:
Source Cluster:
Republished By Plato

San Francisco, February 9, 2022 - Wikisoft Corp. (the “Company,” “we,” and “our”) (OTCQB: WSFT) today announced that it has entered into a non-binding letter of intent to acquire a majority stake in Etheralabs LLC, a New York City based venture lab and ecosystem that invests in, builds, and deploys disruptive technologies across the Blockchain space. The proposed transaction would include full global access to Etheralabs LLC’s disruptive technologies across the Blockchain and global funding landscape. With the majority stake, Wikisoft plans to ensure that Etheralabs future product and technology roadmap supports Wikisoft´s